AllAnalyst Report
logoArgusApril 12, 2021

Humana Inc.: Recent weakness offers buying opportunity.

Symbols
HUM
Sector(s)
Healthcare
Rating
Current Price
$453.75
Price Target
$NaN
Earnings Estimate
Summary

Humana is a health benefits company that offers coordinated health insurance coverage and related services through a variety of plans for retirees, employer groups, and government-sponsored programs, such as Medicare Advantage and Medicaid. Humana serves more than 14 million medical members in fully insured and ASO (administrative services only) plans. The company also has a Health Care services segment that offers, among other things, PBM services, home care services, and primary care services. The company has approximately 49,000 employees. HUM shares are a component of the S&P 500.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free

Analyst Profile

David H. Toung

Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.